Skip to main content
. 2018 Nov 7;8:460. doi: 10.3389/fonc.2018.00460

Figure 2.

Figure 2

Pan-NOTCH/γ-secretase inhibitor BMS-906024 delays cell proliferation of H1299 cells treated with chemoradiation. Luciferase reporter assay (A) and Western Blot (B) of NCI-H1299 and NCI-H460 treated with DMSO (vehicle) or either 0.2 μM dibenzazepine (DBZ), or 0.1 or 1 μM BMS-906024. Incucyte analysis of cell confluency (%) over time of NCI-H1299 cell line for BMS-906024 1μM with/without 2 Gy radiation (C); 2.5 nM paclitaxel (D) or 0.4 μM crizotinib (E) compared to dual treatment including 1 μM BMS-906024 (left) or comparing chemoradiation with 2 Gy to triple combination including 1 μM BMS-906024 (right). A minimum of two independent experiments and 6–18 wells/condition/experiment were tested. Mean and standard error of the mean are plotted.